AbbVie Inc. (ABBV) stock
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3086% above fair value
$286.01−6.81 (-2.33%)
Close on Nov 18, 2026Market cap $505.41BP/E 80.8Yield 2.33%
AbbVie shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
AbbVie's shares outstanding was 1.77B at Jun 30, 2026. For fiscal 2025 it was 1.77B, up 0.0% from the year before. Over ten years it grew 0.8% a year on average. The highest annual figure on record is 1.78B in fiscal 2022.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.77B | 0.0% |
| FY2024 | Dec 31, 2024 | 1.77B | 0.0% |
| FY2023 | Dec 31, 2023 | 1.77B | -0.3% |
| FY2022 | Dec 31, 2022 | 1.78B | +0.1% |
| FY2021 | Dec 31, 2021 | 1.78B | +6.2% |
| FY2020 | Dec 31, 2020 | 1.67B | +12.7% |
| FY2019 | Dec 31, 2019 | 1.48B | -4.0% |
| FY2018 | Dec 31, 2018 | 1.55B | -3.6% |
| FY2017 | Dec 31, 2017 | 1.60B | -1.7% |
| FY2016 | Dec 31, 2016 | 1.63B | -0.4% |
| FY2015 | Dec 31, 2015 | 1.64B | +1.7% |
| FY2014 | Dec 31, 2014 | 1.61B | +0.4% |
| FY2013 | Dec 31, 2013 | 1.60B | +1.7% |
| FY2012 | Dec 31, 2012 | 1.58B | 0.0% |
| FY2011 | Dec 31, 2011 | 1.58B | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 1.77B | 0.0% |
| Q1 FY2026 | Mar 31, 2026 | 1.77B | +0.1% |
| Q4 FY2025 | Dec 31, 2025 | 1.78B | 0.0% |
| Q3 FY2025 | Sep 30, 2025 | 1.77B | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | 1.77B | 0.0% |
| Q1 FY2025 | Mar 31, 2025 | 1.77B | -0.1% |
| Q4 FY2024 | Dec 31, 2024 | 1.78B | 0.0% |
| Q3 FY2024 | Sep 30, 2024 | 1.77B | +0.1% |
| Q2 FY2024 | Jun 30, 2024 | 1.77B | 0.0% |
| Q1 FY2024 | Mar 31, 2024 | 1.77B | -0.2% |
| Q4 FY2023 | Dec 31, 2023 | 1.78B | -0.3% |
| Q3 FY2023 | Sep 30, 2023 | 1.77B | -0.3% |
| Q2 FY2023 | Jun 30, 2023 | 1.77B | -0.3% |
| Q1 FY2023 | Mar 31, 2023 | 1.78B | -0.1% |
| Q4 FY2022 | Dec 31, 2022 | 1.78B | +0.1% |
| Q3 FY2022 | Sep 30, 2022 | 1.78B | -0.1% |
| Q2 FY2022 | Jun 30, 2022 | 1.78B | 0.0% |
| Q1 FY2022 | Mar 31, 2022 | 1.78B | +0.2% |
| Q4 FY2021 | Dec 31, 2021 | 1.78B | -0.1% |
| Q3 FY2021 | Sep 30, 2021 | 1.78B | +0.2% |
| Q2 FY2021 | Jun 30, 2021 | 1.78B | +7.8% |
| Q1 FY2021 | Mar 31, 2021 | 1.77B | +19.6% |
| Q4 FY2020 | Dec 31, 2020 | 1.78B | +19.8% |
| Q3 FY2020 | Sep 30, 2020 | 1.77B | +19.6% |
| Q2 FY2020 | Jun 30, 2020 | 1.65B | +11.0% |
| Q1 FY2020 | Mar 31, 2020 | 1.48B | +0.1% |
| Q4 FY2019 | Dec 31, 2019 | 1.49B | -0.9% |
| Q3 FY2019 | Sep 30, 2019 | 1.48B | -2.1% |
| Q2 FY2019 | Jun 30, 2019 | 1.48B | -5.6% |
| Q1 FY2019 | Mar 31, 2019 | 1.48B | -7.1% |
| Q4 FY2018 | Dec 31, 2018 | 1.50B | -6.5% |
| Q3 FY2018 | Sep 30, 2018 | 1.51B | -5.5% |
| Q2 FY2018 | Jun 30, 2018 | 1.57B | -1.7% |
| Q1 FY2018 | Mar 31, 2018 | 1.60B | -0.4% |
| Q4 FY2017 | Dec 31, 2017 | 1.61B | -1.2% |
| Q3 FY2017 | Sep 30, 2017 | 1.60B | -2.3% |
| Q2 FY2017 | Jun 30, 2017 | 1.60B | – |
| Q1 FY2017 | Mar 31, 2017 | 1.60B | – |
| Q4 FY2016 | Dec 31, 2016 | 1.63B | – |
| Q3 FY2016 | Sep 30, 2016 | 1.64B | – |
See a number that looks wrong?